Floatz logo

WARFARIN

Cerebrovascular Disorder

Seoul National University HospitalSmall moleculePhase 4 / ApprovedActive
BBB
74/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
60/ 100
Competitive Position
95/ 100

Competitive context

12 Active assets in the Cerebrovascular Disorder cohort.

Asset / SponsorPhaseRating
Aspirin
Peking Union Medical College Hospital
Phase 3BB
Cilostazol
Zhejiang Provincial People's Hospital
Phase 3BB
ATORVASTATIN
Sichuan Provincial People's Hospital
Phase 4BB
Tenecteplase
University of Melbourne
Phase 3BB
CLOPIDOGREL
Peking Union Medical College Hospital
Phase 3BB

View all 34 →

Same molecule, other indications

WARFARIN is also rated in:

venous thromboembolismDormant
A
Indicative · Phase 4
81 / 100
View asset →
atrial fibrillationActive
BBB
Indicative · Phase 4
77 / 100
View asset →
hemorrhagic diseaseActive
BBB
Indicative · Phase 4
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →